Grupo de Investigación en Cáncer de Mama
NEONCOBREAST
Université Catholique de Louvain
Louvain-la-Neuve, BélgicaUniversité Catholique de Louvain-ko ikertzaileekin lankidetzan egindako argitalpenak (2)
2020
-
Standard anthracycline based versus docetaxel-capecitabine in early high clinical and/or genomic risk breast cancer in the EORTC 10041/BIG 3-04 MINDACT phase III trial
Journal of Clinical Oncology, Vol. 38, Núm. 11, pp. 1186-1197
2016
-
70-Gene signature as an aid to treatment decisions in early-stage breast cancer
New England Journal of Medicine, Vol. 375, Núm. 8, pp. 717-729